The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Oncolytic Virus Immunotherapy-Global Market Insights and Sales Trends 2025
Synopsis
Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).
The global Oncolytic Virus Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Oncolytic Virus Immunotherapy in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Oncolytic Virus Immunotherapy market. Engineering Oncolytic Viruses, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Wild-Type Oncolytic Viruses segment is estimated at % CAGR for the next seven-year period.
North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oncolytic Virus Immunotherapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oncolytic Virus Immunotherapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oncolytic Virus Immunotherapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oncolytic Virus Immunotherapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oncolytic Virus Immunotherapy covered in this report include Merck, Amgen, TILT Biotherapeutics, Oncorus, Sorrento Therapeutics and Shanghai Sunway Biotech, etc.
The global Oncolytic Virus Immunotherapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Amgen
TILT Biotherapeutics
Oncorus
Sorrento Therapeutics
Shanghai Sunway Biotech
Global Oncolytic Virus Immunotherapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oncolytic Virus Immunotherapy market, Segment by Type:
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses
Global Oncolytic Virus Immunotherapy market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oncolytic Virus Immunotherapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).
The global Oncolytic Virus Immunotherapy market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Oncolytic Virus Immunotherapy in various end use industries. The expanding demands from the Hospitals, Clinics and Ambulatory Surgical Centers,, are propelling Oncolytic Virus Immunotherapy market. Engineering Oncolytic Viruses, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Wild-Type Oncolytic Viruses segment is estimated at % CAGR for the next seven-year period.
North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Oncolytic Virus Immunotherapy, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Oncolytic Virus Immunotherapy market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Oncolytic Virus Immunotherapy market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Oncolytic Virus Immunotherapy sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Oncolytic Virus Immunotherapy covered in this report include Merck, Amgen, TILT Biotherapeutics, Oncorus, Sorrento Therapeutics and Shanghai Sunway Biotech, etc.
The global Oncolytic Virus Immunotherapy market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Amgen
TILT Biotherapeutics
Oncorus
Sorrento Therapeutics
Shanghai Sunway Biotech
Global Oncolytic Virus Immunotherapy market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Oncolytic Virus Immunotherapy market, Segment by Type:
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses
Global Oncolytic Virus Immunotherapy market, by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Oncolytic Virus Immunotherapy companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Oncolytic Virus Immunotherapy
1.1 Oncolytic Virus Immunotherapy Market Overview
1.1.1 Oncolytic Virus Immunotherapy Product Scope
1.1.2 Oncolytic Virus Immunotherapy Market Status and Outlook
1.2 Global Oncolytic Virus Immunotherapy Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Oncolytic Virus Immunotherapy Market Size by Region (2018-2029)
1.4 Global Oncolytic Virus Immunotherapy Historic Market Size by Region (2018-2023)
1.5 Global Oncolytic Virus Immunotherapy Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Oncolytic Virus Immunotherapy Market Size (2018-2029)
1.6.1 North America Oncolytic Virus Immunotherapy Market Size (2018-2029)
1.6.2 Europe Oncolytic Virus Immunotherapy Market Size (2018-2029)
1.6.3 Asia-Pacific Oncolytic Virus Immunotherapy Market Size (2018-2029)
1.6.4 Latin America Oncolytic Virus Immunotherapy Market Size (2018-2029)
1.6.5 Middle East & Africa Oncolytic Virus Immunotherapy Market Size (2018-2029)
2 Oncolytic Virus Immunotherapy Market by Type
2.1 Introduction
2.1.1 Engineering Oncolytic Viruses
2.1.2 Wild-Type Oncolytic Viruses
2.2 Global Oncolytic Virus Immunotherapy Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Type (2018-2023)
2.2.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Oncolytic Virus Immunotherapy Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Oncolytic Virus Immunotherapy Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Oncolytic Virus Immunotherapy Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Oncolytic Virus Immunotherapy Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Oncolytic Virus Immunotherapy Revenue Breakdown by Type (2018-2029)
3 Oncolytic Virus Immunotherapy Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Ambulatory Surgical Centers
3.2 Global Oncolytic Virus Immunotherapy Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Application (2018-2023)
3.2.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Oncolytic Virus Immunotherapy Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Oncolytic Virus Immunotherapy Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Oncolytic Virus Immunotherapy Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Oncolytic Virus Immunotherapy Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Oncolytic Virus Immunotherapy Revenue Breakdown by Application (2018-2029)
4 Oncolytic Virus Immunotherapy Competition Analysis by Players
4.1 Global Oncolytic Virus Immunotherapy Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Oncolytic Virus Immunotherapy as of 2022)
4.3 Date of Key Players Enter into Oncolytic Virus Immunotherapy Market
4.4 Global Top Players Oncolytic Virus Immunotherapy Headquarters and Area Served
4.5 Key Players Oncolytic Virus Immunotherapy Product Solution and Service
4.6 Competitive Status
4.6.1 Oncolytic Virus Immunotherapy Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Merck
5.1.1 Merck Profile
5.1.2 Merck Main Business
5.1.3 Merck Oncolytic Virus Immunotherapy Products, Services and Solutions
5.1.4 Merck Oncolytic Virus Immunotherapy Revenue (US$ Million) & (2018-2023)
5.1.5 Merck Recent Developments
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business
5.2.3 Amgen Oncolytic Virus Immunotherapy Products, Services and Solutions
5.2.4 Amgen Oncolytic Virus Immunotherapy Revenue (US$ Million) & (2018-2023)
5.2.5 Amgen Recent Developments
5.3 TILT Biotherapeutics
5.3.1 TILT Biotherapeutics Profile
5.3.2 TILT Biotherapeutics Main Business
5.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Products, Services and Solutions
5.3.4 TILT Biotherapeutics Oncolytic Virus Immunotherapy Revenue (US$ Million) & (2018-2023)
5.3.5 Oncorus Recent Developments
5.4 Oncorus
5.4.1 Oncorus Profile
5.4.2 Oncorus Main Business
5.4.3 Oncorus Oncolytic Virus Immunotherapy Products, Services and Solutions
5.4.4 Oncorus Oncolytic Virus Immunotherapy Revenue (US$ Million) & (2018-2023)
5.4.5 Oncorus Recent Developments
5.5 Sorrento Therapeutics
5.5.1 Sorrento Therapeutics Profile
5.5.2 Sorrento Therapeutics Main Business
5.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Products, Services and Solutions
5.5.4 Sorrento Therapeutics Oncolytic Virus Immunotherapy Revenue (US$ Million) & (2018-2023)
5.5.5 Sorrento Therapeutics Recent Developments
5.6 Shanghai Sunway Biotech
5.6.1 Shanghai Sunway Biotech Profile
5.6.2 Shanghai Sunway Biotech Main Business
5.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Products, Services and Solutions
5.6.4 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Revenue (US$ Million) & (2018-2023)
5.6.5 Shanghai Sunway Biotech Recent Developments
6 North America
6.1 North America Oncolytic Virus Immunotherapy Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Oncolytic Virus Immunotherapy Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Oncolytic Virus Immunotherapy Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Oncolytic Virus Immunotherapy Market Dynamics
11.1 Oncolytic Virus Immunotherapy Industry Trends
11.2 Oncolytic Virus Immunotherapy Market Drivers
11.3 Oncolytic Virus Immunotherapy Market Challenges
11.4 Oncolytic Virus Immunotherapy Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
